利拉格卢提德作为治疗犬超重症的新药:一项临床研究
Burak Dik1, Durmuş Hatipoglu2, Oguzhan Kahraman3
1Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Selcuk University, Konya 42130, Turkey.
Veterinary journal (London, England : 1997)
|May 28, 2025
概括
老年犬的利拉格卢提德治疗显示出通过降低身体状况评分和抑制食欲来控制犬类肥胖的潜力. 虽然体重减轻没有统计学意义,但胆固醇和甘油三水平下降,这表明治疗效益.
科学领域:
- 兽医医学 兽医医学 兽医医学
- 狗的健康 狗的健康
- 药理学 药理学是指药理学的学科.
背景情况:
- 狗肥胖是一种多因素的疾病,与饮食不良,不活动和遗传有关.
- 肥胖增加了狗的严重健康问题的风险,包括糖尿病和心血管疾病.
研究的目的:
- 为了评估liraglutide在衰老中的减肥效果,超重的狗缺乏足够的运动和不良饮食.
- 评估liraglutide对狗的身体状况,体重和代谢标志物的影响.
主要方法:
- 21名老年黄金回归犬被分为三个组:健康的对照组,饮食中肥胖的狗和饮食中肥胖的狗加上利拉格卢提德.
- 这项研究涉及40天的试验,在治疗组中,每天进行皮下利拉格胺剂 (1.2毫克/狗) 的治疗.
主要成果:
- 利拉格卢提德治疗导致身体状况得分和体重下降,尽管在统计学上并不显著.
- 观察到胆固醇和甘油三水平显著降低.
- 胃口测试表明,用利拉格卢提德治疗的狗明显抑制了食物摄入.
结论:
- 利拉格卢提德 (Liraglutide) 显示出作为潜在的抗肥胖药物对狗的承诺.
- 需要进行进一步的长期研究,以确定利拉格卢提德在狗肥胖管理中的有效性和最佳使用.
相关概念视频
Glucagon-like Receptor Agonists
438
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
438
Acute Pancreatitis II: Clinical Manifestations and Management
186
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
186
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
212
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
212
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
432
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
432
Chronic Pancreatitis II: Collaborative Care
133
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
133
Obesity
631
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
631


